Arcturus Therapeutics Holdings Inc. (ARCT)
Data as of , from SEC Form 4 filings.
See up to 3 months of ARCT. The 7-day demo opens the 1M and 3M ranges and puts ARCT on your watchlist.
Start 7-day demoLatest ARCT insider trades
About Arcturus Therapeutics Holdings Inc. (ARCT)
The SEC lists Arcturus Therapeutics Holdings Inc. under CIK 0001768224, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
ARCT Form 4 activity by transaction type, last 90 days
No Form 4 activity for ARCT in the last 90 days.
ARCT insider transactions (Form 4)
1717 Form 4 filings on record, the earliest from Oct 16, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Edward W. Holmes - Director | Grant or award | Stock option (right to buy) | 15,000 | $0.00 | - | |
| Peter C. Farrell - Director | Grant or award | Stock option (right to buy) | 15,000 | $0.00 | - | |
| James F. Barlow - Director | Grant or award | Stock option (right to buy) | 15,000 | $0.00 | - | |
| John Markels - Director | Grant or award | Stock option (right to buy) | 15,000 | $0.00 | - | |
| Moncef Slaoui - Director | Grant or award | Stock option (right to buy) | 15,000 | $0.00 | - | |
| Magda Marquet - Director | Grant or award | Stock option (right to buy) | 15,000 | $0.00 | - | |
| Jing L. Marantz - Director | Grant or award | Stock option (right to buy) | 15,000 | $0.00 | - | |
 Dennis Mulroy - Officer | Grant or award | Employee Stock Option (right to buy) | 100,000 footnote F1 | $0.00 | - | |
| ||||||
| Andy Sassine - Officer | Open-market purchase | Common Stock | 1,238 | $16.56 | $20K | |
| Edward W. Holmes - Director | Grant or award | Stock option (right to buy) | 15,000 | $0.00 | - | |
| James F. Barlow - Director | Grant or award | Stock option (right to buy) | 15,000 | $0.00 | - | |
| Peter C. Farrell - Director | Grant or award | Stock option (right to buy) | 15,000 | $0.00 | - | |
| Lance Kurata - Officer | Grant or award | Employee Stock Option (right to buy) | 60,000 | $0.00 | - | |
| Pad Chivukula - Officer | Grant or award | Employee Stock Option (right to buy) | 60,000 | $0.00 | - | |
| Joseph E. Payne - Officer | Grant or award | Employee Stock Option (right to buy) | 196,000 | $0.00 | - | |
| Andy Sassine - Officer | Grant or award | Employee Stock Option (right to buy) | 60,000 | $0.00 | - | |
| Pad Chivukula - Officer | Open-market sale | Common Stock | 12,000 | $20.76 | $249K | |
ARCT insider trading FAQ
What is the latest insider trade for ARCT?
Arcturus Therapeutics Holdings Inc. (ARCT) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-15. The full record for ARCT runs to 17 Form 4 filings, the earliest from 2024-10-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ARCT stock?
No insider purchases of ARCT were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling ARCT stock?
No insider sales of ARCT were filed in the last 90 days. 1 sale is on record for this company.
Where can I see ARCT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ARCT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Edward W. Holmes view on EDGAR
- - Peter C. Farrell view on EDGAR
- - James F. Barlow view on EDGAR
- - John Markels view on EDGAR
- - Moncef Slaoui view on EDGAR
- - Magda Marquet view on EDGAR
- - Jing L. Marantz view on EDGAR
- - Dennis Mulroy view on EDGAR
- - Andy Sassine view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ARCT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ARCT with a 7-day demo
- ARCT on your watchlist
- Every ARCT Form 4 filing on record
- Up to 3 months of ARCT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
